Related posts
Fed jitters pressure marketsThis summary was created by AI, based on 4 opinions in the last 12 months.
Centene (CNC-N) is facing technical challenges with lower lows and lower highs, indicating a negative trend. However, it is currently testing support from 2023, which could potentially improve the picture. Stockchase Research Editor Michael O'Reilly sees Centene as a provider of healthcare to under-insured families and military personnel in the US, with growing cash reserves, debt retirement, and stock buybacks. The company is trading at a reasonable valuation with considerable upside potential. Overall, while there are technical challenges, the fundamentals of Centene remain strong.
About as cheap as it's been in the last 5 years at 1.25x book. FMV is 93% above current price. Earnings and FMV continue to rise. A good buying opportunity.
Centene is a American stock, trading under the symbol CNC-N on the New York Stock Exchange (CNC). It is usually referred to as NYSE:CNC or CNC-N
In the last year, 1 stock analyst published opinions about CNC-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Centene.
Centene was recommended as a Top Pick by on . Read the latest stock experts ratings for Centene.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered Centene In the last year. It is a trending stock that is worth watching.
On 2024-12-13, Centene (CNC-N) stock closed at a price of $59.39.
Support level has definitely been broken. Lower lows, lower highs. All that is negative technically. Looking at a 3-year chart, now testing support from 2023. If that can hold, it's not so bad a picture.